This report studies Human Embryonic Stem Cells (HESC) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Astellas Pharma Inc/ Ocata Therapeutics STEMCELL Technologies BIOTIME, INC Thermo Fisher Scientific CellGenix ESI BIO PromoCell Lonza Kite Pharma Cynata Sumanas LifeCell Geron Millipore BD Biosciences Genea BioCells By types, the market can be split into Adult Sources Fetal Sources By Application, the market can be split into Regenerative Medicine Stem Cell Biology Research Tissue Engineering Toxicology Testing By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India
Table of Contents Global Human Embryonic Stem Cells (HESC) Market Professional Survey Report 2017 1 Industry Overview of Human Embryonic Stem Cells (HESC) 1.1 Definition and Specifications of Human Embryonic Stem Cells (HESC) 1.1.1 Definition of Human Embryonic Stem Cells (HESC) 1.1.2 Specifications of Human Embryonic Stem Cells (HESC) 1.2 Classification of Human Em